Cargando…

Finding the optimal treatment sequence in metastatic castration-resistant prostate cancer—a narrative review

Over the last two decades, there has been significant progress in the treatment of metastatic prostate cancer. Multiple treatments with diverse mechanisms of action have improved clinical outcomes for patients with metastatic castration-resistant prostate cancer (mCRPC) including taxane chemotherapy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maurice Dror, Corinne, Chi, Kim N., Khalaf, Daniel J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Review Article on Management of Advanced Genitourinary Malignancies
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575566/ https://www.ncbi.nlm.nih.gov/pubmed/34804836 http://dx.doi.org/10.21037/tau-20-1341

Ejemplares similares

Narrative review: prostate-specific membrane antigen-radioligand therapy in metastatic castration-resistant prostate cancer
por: Lunger, Lukas, et al.
Publicado: (2021)

A marrow-minded look at immune checkpoint blockade resistance in metastatic castration resistant prostate cancer
por: Fonseca, Nicolette M., et al.
Publicado: (2021)

KDM5D predicts response to docetaxel chemotherapy in metastatic castration resistant prostate cancer patients
por: Schäfer, Georg, et al.
Publicado: (2021)

ALP bouncing and LDH normalization in bone metastatic castration-resistant prostate cancer patients under therapy with Enzalutamide: an exploratory analysis
por: Schlack, Katrin, et al.
Publicado: (2021)

Current treatment options for newly diagnosed metastatic hormone-sensitive prostate cancer—a narrative review
por: Ong, Sean, et al.
Publicado: (2021)

Narrative review of challenges in the management of advanced neuroendocrine prostate cancer
por: Okasho, Kosuke, et al.
Publicado: (2021)

Narrative review of developing new biomarkers for decision making in advanced testis cancer
por: Nappi, Lucia, et al.
Publicado: (2021)

(177)Lu-PSMA Therapy for Metastatic Castration-Resistant Prostate Cancer: A Mini-Review of State-of-the-Art
por: AlSadi, Rahaf, et al.
Publicado: (2022)

Combination therapies involving checkpoint-inhibitors for treatment of urothelial carcinoma: a narrative review
por: Schulz, Gerald B., et al.
Publicado: (2021)

Update on systemic treatment of upper tract urothelial carcinoma: a narrative review of the literature
por: Gust, Kilian M., et al.
Publicado: (2021)

Characteristics of upper urinary tract urothelial carcinoma in the context of bladder cancer: a narrative review
por: Giudici, Nicola, et al.
Publicado: (2021)

Real-World Treatment Patterns Among Patients With Metastatic Castration-Resistant Prostate Cancer: Results From an International Study
por: Barata, Pedro C, et al.
Publicado: (2023)

Optimization of Radium-223 Treatment of Castration-resistant Prostate Cancer Based on the Burden of Skeletal Metastasis and Clinical Parameters
por: Shariftabrizi, Ahmad, et al.
Publicado: (2023)

Systemic treatment of penile squamous cell carcinoma—hurdles and hopes of preclinical models and clinical regimens: a narrative review
por: Thomas, Anita, et al.
Publicado: (2021)

Visceral Metastasis Predicts Response to New Hormonal Agents in Metastatic Castration-Sensitive Prostate Cancer
por: Yekedüz, Emre, et al.
Publicado: (2023)

Preface to “Management of advanced genitourinary malignancies”
por: Todenhöfer, Tilman
Publicado: (2021)

ADXS31142 Immunotherapy ± Pembrolizumab Treatment for Metastatic Castration-Resistant Prostate Cancer: Open-Label Phase I/II KEYNOTE-046 Study
por: Stein, Mark N, et al.
Publicado: (2022)

Plasma Exosomal AKR1C3 mRNA Expression Is a Predictive and Prognostic Biomarker in Patients with Metastatic Castration-Resistant Prostate Cancer
por: Zhu, Sha, et al.
Publicado: (2022)

Prostate specific membrane antigen-radio guided surgery using Cerenkov luminescence imaging—utilization of a short-pass filter to reduce technical pitfalls
por: Darr, Christopher, et al.
Publicado: (2021)

Real-World Treatment Trends Among Patients with Metastatic Castration-Sensitive Prostate Cancer: Results from an International Study
por: Barata, Pedro C, et al.
Publicado: (2023)

Talazoparib, a Poly(ADP-ribose) Polymerase Inhibitor, for Metastatic Castration-resistant Prostate Cancer and DNA Damage Response Alterations: TALAPRO-1 Safety Analyses
por: Mehra, Niven, et al.
Publicado: (2022)

Oncological validation of bone turnover markers c-terminal telopeptide of type I collagen (1CTP) and peptides n-terminal propeptide of type I procollagen (P1NP) in patients with prostate cancer and bone metastases
por: Aufderklamm, Stefan, et al.
Publicado: (2021)

Diffusion-Weighted Magnetic Resonance Imaging for the Evaluation of Prostate Cancer: Optimal B Value at 3T
por: Koo, Ji Hyun, et al.
Publicado: (2013)

A tertiary care audit of using abiraterone acetate in patients of metastatic castrate-resistant prostate cancer
por: Joshi, Amit, et al.
Publicado: (2020)

Treatment options for advanced urothelial cancer after progression on chemotherapy and immune checkpoint inhibitors: a literature review
por: Koshkin, Vadim S., et al.
Publicado: (2021)

Assessment of prognosis by established prognosis scores and physicians’ judgement in mRCC patients: an analysis of the STAR-TOR registry
por: Boegemann, Martin, et al.
Publicado: (2021)

Twin pregnancy with metastatic complete molar pregnancy and coexisting live fetus
por: Odedra, Devang, et al.
Publicado: (2019)

Extragastrointestinal stromal tumor presenting as an exophytic prostatic mass
por: Nguyen Thanh, Thao, et al.
Publicado: (2020)

Case series: Diffusion weighted MRI appearance in prostatic abscess
por: Singh, Paramjeet, et al.
Publicado: (2011)

Magnetic resonance imaging findings in ovarian torsion post in vitro fertilization
por: Al Salmi, Ishaq S., et al.
Publicado: (2018)

Isolation and genomic analysis of circulating tumor cells from castration resistant metastatic prostate cancer
por: Magbanua, Mark Jesus M, et al.
Publicado: (2012)

Multiparametric ultrasound findings of tuberculous orchitis following bacillus Calmette-Guérin therapy
por: Ahmed, Rumman, et al.
Publicado: (2017)

Congenital kidney malformation: Computed tomography and scintigraphy findings of renal reversed rotation
por: Di Giuliano, Francesca, et al.
Publicado: (2019)

Imaging findings of a torsed pedunculated uterine leiomyoma: A case report
por: Le, David, et al.
Publicado: (2019)

Multimodality approach to imaging giant multilocular cystadenoma of the prostate: A rare entity
por: El-Asmar, Jose M., et al.
Publicado: (2019)

MR imaging findings in perineal nodular induration (“cyclist´s nodule”): A case report
por: De Cima, Andrea, et al.
Publicado: (2020)

Giant multilocular prostatic cystadenoma, a diagnosis to consider in large pelvic male masses
por: Portugal Teixeira, Inês, et al.
Publicado: (2019)

Incidental imaging findings suggesting Zinner syndrome in a young patient with pulmonary embolism: A case report
por: Hergan, Benedikt, et al.
Publicado: (2020)

Transformation of adenocarcinoma of prostate to squamous cell carcinoma following hormonal treatment: A case report and review of the literature
por: Lee, Jihyun
Publicado: (2019)

Multi-institutional Analysis of the Clinical and Genomic Characteristics of Black Patients with Metastatic Hormone-Sensitive Prostate Cancer
por: Freeman, Meredith N, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nb2v2u7rr6taiipb4t63p7d542